News

A new study details the development of a nanoparticle-based system that delivers concentrated chemotherapy specifically to ...
Datroway (datopotamab deruxtecan) is the first TROP2-directed therapy approved for advanced lung cancer in the U.S.
For the first time, scientists have systematically studied the genetic effects of chemotherapy on healthy tissues.
In a detail-thin announcement, Amgen said that adding bemarituzumab to chemotherapy improved overall survival, though ...
Esophageal adenocarcinoma (EAC), one of two major forms of esophageal cancer, is the sixth most deadly cancer worldwide for ...
Bemarituzumab targets FGFR2b, which has been found to be overexpressed in approximately 30% of patients with non-HER2 positive gastric cancer.
New DNA test predicts chemotherapy resistance before treatment, potentially sparing patients from ineffective toxic drugs.
Multiple myeloma begins when abnormal cells multiply and grow uncontrollably in a person’s bone marrow, crowding out healthy ...
After six cycles of chemotherapy, Cesca Litton is finally done and is looking forward to her next battle with breast cancer.